Dr John Nash, Senior Director ADME/PK, BioFocus
pharmafile | November 3, 2009 | Appointment | Research and Development | appointment, biofocus, research and development
BioFocus, a leading provider of gene-to-drug candidate discovery services, has appointed Dr John Nash as senior director, ADME/PK.
John has 30 years industrial experience with both service and major pharma companies.
Most recently, John worked for eight years for Charles River Laboratories in Quebec, Canada, where he was responsible for strengthening the DMPK service business, and making it a successful, revenue generating operation. Prior to moving to Canada, John worked in the UK with Anserve and AstraZeneca/Syngenta in metabolism and pharmacokinetics. John holds an M. Phil. degree from the University of Surrey and a Ph.D. degree from the University of Manchester.
“John Nash’s appointment is a major win for BioFocus in the UK,” commented Dr Chris Newton, SVP BioFocus. “With this hire, BioFocus continues to elevate its 175 scientist facility at Chesterford Research Park into a leading integrated discovery research center for pharma, biotech and not-for-profit organisations worldwide.”
Related Content

PlasmidFactory founder Dr. Martin Schleef honoured with the NRW Innovation Award 2025
The founder and long-standing CEO of PlasmidFactory, Dr. Martin Schleef, was honoured in Düsseldorf with …

AAX Biotech announces collaboration for cardiovascular antibody therapy
Swedish biotech firm AAX Biotech has entered a new collaboration focused on the development of …

Research finds tablet effective in slowing progression of Alzheimer’s disease over 18 months
TauRx Pharmaceutics reports that hydromethylthionine mesylate (HMTM) could be an oral treatment for slowing the …






